Navigation Links
Top Australian malaria researcher elected Fellow of the Royal Society
Date:5/20/2011

Internationally recognised malaria researcher Professor Alan Cowman from the Walter and Eliza Hall Institute in Melbourne, Australia, has been elected a Fellow of the Royal Society, the UK's peak academy promoting excellence in science.

Professor Cowman is one of 44 new fellows inducted to the Royal Society in 2011, including four Australians. Fellows are nominated and selected through a peer review process on the basis of excellence in science.

Professor Cowman has had a major impact on infectious disease research in the field of malaria. He has spent the past 30 years studying the parasite Plasmodium falciparum, which causes the most deadly form of malaria in humans. The research has led to a better understanding of how the malaria parasite evades detection by the human immune system and how it becomes resistant to anti-malarial drugs.

Professor Cowman said he was deeply honoured to receive the nomination and be elected to the society. "It is very pleasing to receive the award because it recognises the quality and impact of our research in malaria, an area in which Australia makes a major contribution," he said. "I would like to thank and acknowledge my mentors and importantly the colleagues with whom I have worked and collaborated over the years to make our work successful. I am indebted to the Walter and Eliza Hall Institute for its continuing support of our research which has been so important to our success."

Each year almost 250 million people contract malaria, and one million people, mostly children, die from the disease. "Malaria presents an enormous health burden but also has a major impact on social and economic development in countries where the disease is endemic," Professor Cowman said. "New therapies are urgently needed."

Professor Cowman has made major contributions to understanding drug resistance, elucidating the mechanism of resistance to some of the most important antimalarial drugs. This has had implications for the development of new antimalarial treatments and opened the way for surveillance of the geographic spread of drug-resistant strains of malaria.

His research has revealed significant detail about how the P. falciparum malaria parasite invades and remodels human red blood cells to multiply and establish infection while escaping the immune responses deployed against it. Collectively, this knowledge is being used to identify vaccine and drug candidates against malaria.

Professor Cowman and his colleagues have received funding from PATH Malaria Vaccine Initiative (MVI) to progress a 'multi-component subunit' vaccine into clinical development; the vaccine is made up of three proteins they identified as being critical for the function of the parasite. The research has also led Professor Cowman and his colleagues to develop the first potential malaria vaccine that uses a whole, genetically modified malaria parasite to protect against infection. The malaria vaccine began human Phase I trials in 2010, with funding from the Bill & Melinda Gates Foundation and in collaboration with the Seattle Biomedical Research Institute, and Walter Reed Army Institute of Research.

Professor Doug Hilton, director of the Walter and Eliza Hall Institute, said he was pleased to see Professor Cowman's contribution to the field of malaria recognised by the society. "Professor Cowman has developed tools and knowledge that have greatly increased understanding of the malaria parasite and how it causes disease in humans. We are now at the stage of seeing those critical discoveries pave the way for new vaccines and treatments for the prevention of malaria, which could have an enormous impact on the three billion people at-risk of contracting malaria across the globe," he said.

Fellow Australians Professor Ian Frazer, Professor Mark Randolph and Dr Patrick Tam were also honoured with a Royal Society Fellowship this year. The Royal Society was established in 1660, and fellows include such prominent scientists and mathematicians as Sir Charles Darwin and Sir Isaac Newton. Walter and Eliza Hall alumni Sir Macfarlane Burnet, Sir Gus Nossal and Professor Jacques Miller as well as current faculty Professor Don Metcalf, Professor Suzanne Cory and Professor Jerry Adams are all Royal Society Fellows.


'/>"/>

Contact: Liz Williams
williams@wehi.edu.au
61-405-279-095
Walter and Eliza Hall Institute
Source:Eurekalert  

Related biology news :

1. Experts propose global guidelines for safe use of Kava and new Australian study
2. Elsevier congratulates Royal Australian Chemical Institutes Athel Beckwith Lectureship winner
3. World interest in Australian fishery impact test
4. Male Australian redback spiders employ courtship strategies to preserve their life
5. Australian study sheds light on kidney repair and disease
6. Energy experts helping Australian households reduce carbon emissions
7. Australian filmmakers are stars of science film awards
8. Crafty Australian crayfish cheat
9. Malaria against malaria: A pre-existing malaria infection can prevent a second infection
10. €12 million ($16.9 million) project to develop new tools for malaria control
11. Insight into parasite family planning could help target malaria
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Top Australian malaria researcher elected Fellow of the Royal Society
(Date:6/21/2016)... VANCOUVER, British Columbia , June 21, 2016 ... been appointed to the new role of principal ... has been named the director of customer development. ... , NuData,s chief technical officer. The moves reflect ... development teams in response to high customer demand ...
(Date:6/9/2016)... , June 9, 2016 ... Police deploy Teleste,s video security solution to ensure the safety ... France during the major tournament Teleste, ... communications systems and services, announced today that its video security ... to back up public safety across the country. ...
(Date:6/2/2016)... , June 2, 2016 Perimeter ... Platforms, Unmanned Systems, Physical Infrastructure, Support & Other Service  ... visiongain offers comprehensive analysis of the global ... market will generate revenues of $17.98 billion in 2016. ... DVTEL Inc, a leader in software and hardware technologies ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
(Date:6/23/2016)...  The Prostate Cancer Foundation (PCF) is pleased to announce 24 ... for prostate cancer. Members of the Class of 2016 were selected from a ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... ... In a new case report published today in STEM CELLS Translational Medicine, doctors ... being treated for breast cancer benefitted from an injection of stem cells derived from ... frequent side effect of cancer treatment. , Lymphedema refers to the swelling ...
Breaking Biology Technology: